NCT00001269View on ClinicalTrials.gov

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 1991

Study Completion Date

February 28, 2001

Conditions
Breast NeoplasmsNeoplasm Metastasis
Interventions
DRUG

IL-3

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH